TERT gene: its function and dysregulation in cancer

2019/01/29 by Andrew J Colebatch, Andrew J. Colebatch, Alexander Dobrovic +2 · 25 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Telomeres, Telomerase, and Senescence #Cancer Research and Treatments

paper · pdf · doi:10.1136/jclinpath-2018-205653

Abstract

In this review, we summarise the function and structure of telomerase reverse transcriptase ( TERT ) in humans, including its regulation. The dysregulation of telomerase through TERT promoter mutations across a range of cancers is discussed. The molecular mechanism activated by TERT promoter mutations is outlined. Finally, the timing of TERT promoter mutations during carcinogenesis is reviewed in the context of their potential utility as clinical biomarkers of malignant transformation.

Citations

• The serial cultivation of human diploid cell strains

Cited by

• CDK7 inhibitor suppresses tumor progression through blocking the cell cycle at the G2/M phase and inhibiting transcriptional activity in cervical cancer. [europepmc]
• Onset of Telomere Dysfunction and Fusions in Human Ovarian Carcinoma. [europepmc]
• Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease. [europepmc]
• Pan-cancer analysis identifies TERT alterations as predictive biomarkers for immune checkpoint inhibitors treatment. [europepmc]
• Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming. [europepmc]
• TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of Gliomas. [europepmc]
• Emerging roles of DYRK2 in cancer. [europepmc]
• Progression of Papillary Thyroid Carcinoma to Anaplastic Carcinoma in Metastatic Lymph Nodes: Solid/Insular Growth and Hobnail Cell Change in Lymph Nodes Are Predictors of Subsequent Anaplastic Transformation. [europepmc]
• LPCAT1-TERT fusions are uniquely recurrent in epithelioid trophoblastic tumors and positively regulate cell growth. [europepmc]
• Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis. [europepmc]
• Current Advances on the Important Roles of Enhancer RNAs in Molecular Pathways of Cancer. [europepmc]
• TRIM28 is a transcriptional activator of the mutant TERT promoter in human bladder cancer. [europepmc]
• Bibliometric Insights in Advances of Anaplastic Thyroid Cancer: Research Landscapes, Turning Points, and Global Trends. [europepmc]
• Identification of Key Deregulated RNA-Binding Proteins in Pancreatic Cancer by Meta-Analysis and Prediction of Their Role as Modulators of Oncogenesis. [europepmc]
• Novel Insights into the Therapeutic Potential of Lung-Targeted Gene Transfer in the Most Common Respiratory Diseases. [europepmc]
• Cell senescence and malignant transformation in the inherited bone marrow failure syndromes: Overlapping pathophysiology with therapeutic implications. [europepmc]
• A genome-wide cross-cancer meta-analysis highlights the shared genetic links of five solid cancers. [europepmc]
• Reverse-ChIP Techniques for Identifying Locus-Specific Proteomes: A Key Tool in Unlocking the Cancer Regulome. [europepmc]
• Association of TERT (rs2736098 and rs2736100) genetic variants with elevated risk of hepatocellular carcinoma: a retrospective case-control study. [europepmc]
• miRNAs and related genetic biomarkers according to the WHO glioma classification: From diagnosis to future therapeutic targets. [europepmc]
• Two co-inherited SNPs of the telomerase reverse transcriptase (TERT) gene are associated with Iraqi patients with lung cancer. [europepmc]
• Molecular mechanisms of tumour development in glioblastoma: an emerging role for the circadian clock. [europepmc]
• The tripartite motif-containing 24 is a multifunctional player in human cancer. [europepmc]
• Context-aware single-cell multiomics approach identifies cell-type-specific lung cancer susceptibility genes. [europepmc]
• Modernizing Neuro-Oncology: The Impact of Imaging, Liquid Biopsies, and AI on Diagnosis and Treatment. [europepmc]

Related

• CRISPR/Cas9-mediated TERT disruption in cancer cells
• Transcription factor AP-4 (TFAP4) unleashes telomerase reverse transcriptase (TERT) activity in non-viral-associated liver cancers
• Transcription factor AP-4 reactivates telomerase reverse transcriptase independently of genome alteration in non-HBV associated hepatocellular carcinoma
• Learning From Cancer: Extending Cell Viability by Telomerase Modulation
• TERT rs10069690 variant is linked to reduced cholangiocarcinoma incidence but adverse prognosis in patients undergoing resection